Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
GenNext Technologies is a platform that provides instrumentation, software, and services to structural biology researchers.
RocketML is a Super Fast Computational engine for Machine Learning.
O2 RegenTech is commercializing cost-effective, easy-to-use wound care solutions.
Trace Biosciences creates fluorescence imaging agents for real-time nerve visualization during surgery.
Epitel is a medical technology company that develops wearable EEG devices and software for neurological monitoring and data analysis.
SEngine Precision Medicine uses algorithms and 3D organoid technology to develop drugs with more efficacy.
Opsin Biotherapeutics develops a pipeline of opsin-based gene therapies for pain management
Venova is creating a unique method of birth control for women that is long-acting, extremely effective, and free of adverse effects.
MaMome uses microbiome analysis and ML to improve maternal health by detecting high-risk pregnancies early.
Atom Bioworks is a developer of a pattern-recognition enabled sensing and therapeutics platform designed to help in medical.
Advent Therapeutics is focused on providing therapies for micro-orphan applications.
Caeregen Therapeutics is committed to finding and creating innovative medicinal solutions.
Sapphiros invests in growth-stage diagnostic companies, focusing on technologies that prioritize innovation and patient-centric approaches.
Gel4Med is the Smart Materials Company paving the way to the future of regenerative medicine.
Opticyte is transforming care for the leading causes of organ failure, including sepsis, with real-time measurements.
Intact Genomics provides high-quality life science products and large DNA fragment cloning related services
Orlance provides more effective therapeutic and preventive vaccines for a wide spectrum of viral targets.
BiaCure Therapies an emerging innovator in non-invasive medical technology,
POP Biotechnologies LLC is Buffalo NY biotechnology company.
Lamassu Pharma is a biotech startup that solves the critical unmet medical need for severe acute pancreatitis.
Spike Neuro is a biotechnology company that offers neural research device performance using innovative materials and engineering design.
Metaclipse Therapeutics Corporation is a preclinical-stage biotechnology company
Kintara Therapeutics is engaged in developing and commercializing therapies for the treatment of cancer patients.
Max-IR Labs develops infrared chemical and thermal sensor technology for defence-related products.
National Institutes of Health has invested in 491 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institutes of Health's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Medical Device. The firm invests across 29 different industry categories.
Among tracked funding rounds, Epitel received $26.0M in a Series B round. National Institutes of Health's total known invested capital is $1.9B.
National Institutes of Health's average investment size is $4.9M across its portfolio of 491 companies.
Recent National Institutes of Health portfolio additions include GenNext Technologies, RocketML, O2 RegenTech, Trace Biosciences, Epitel. These companies were founded in 2020 or later.